Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/10562
Title: Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.
Authors: Azzam, Omar
Crowe, Amy
Sajiv, Cherian
Pawar, Basant
Affiliation: Department of Nephrology, Alice Springs Hospital, Alice Springs, Northern Territory, Australia..
Department of Microbiology, Royal Darwin Hospital, Alice Springs, Northern Territory, Australia..
Alice Springs Hospital, Alice Springs, Northern Territory, Australia..
Department of Nephrology, Alice Springs Hospital, Alice Springs, Northern Territory, Australia..
Issue Date: 5-Oct-2015
Citation: BMJ case reports 2015-10-05; 2015
Abstract: A 33-year-old Caucasian man with end-stage renal disease secondary to biopsy-proven IgA nephropathy, managed with continuous ambulatory peritoneal dialysis (PD), presented with PD-related peritonitis, the causal organism being a non-branching Gram-positive bacillus, Rhodococcus equi. Initial empirical Gram positive and negative coverage with cefazolin and ceftazidime was unsuccessful, but following isolation of the organism, and conversion to intraperitoneal vancomycin and oral ciprofloxacin, the peritonitis episode resolved. At day 10, vancomycin was switched to azithromycin for a total of 6 weeks of antimicrobial therapy. The PD catheter was preserved, and the patient remained peritonitis-free at 6 months of follow-up.
URI: http://docs.prosentient.com.au/prosentientjspui/handle/1/10562
DOI: 10.1136/bcr-2014-207753
Type: Case Reports
Journal Article
Subjects: Actinomycetales Infections
Adult
Anti-Infective Agents
Australia
Azithromycin
Ciprofloxacin
Drug Therapy, Combination
Follow-Up Studies
Humans
Kidney Failure, Chronic
Male
Peritoneal Dialysis, Continuous Ambulatory
Peritonitis
Rhodococcus equi
Treatment Outcome
Vancomycin
Appears in Collections:NT Health digital library

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.